Zealand's Dutch leading investor looks forward to two hectic years: "There are more triggers"

Head of Investments for the Dutch family foundation Van Herk, Dharminder Chahal, is looking forward to getting certainty over a number of central points in Zealand Pharma's business plan over the next two years, where the company reaches several milestones.